Dow Component Johnson & Johnson (JNJ)...

Dow Component Johnson & Johnson (JNJ) To Go Ex-dividend Tomorrow

There are 1 comment on the story from Aug 23, 2012, titled Dow Component Johnson & Johnson (JNJ) To Go Ex-dividend Tomorrow. In it, reports that:

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors.

Join the discussion below, or


Brooklyn, NY

#1 Aug 24, 2012
Thank you for this interesting details about Johnson and Johnson valuation and prospective market. Check this site for more details on hip replacement related issues

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

DePuy Orthopaedics Discussions

Title Updated Last By Comments
News DePuy ASR Hip Lawsuit Update: Federal ASR Hip L... (Jul '13) Aug '16 Dirk 2
2015 Osun state college of health tecgnology fo... (Apr '15) Apr '15 Mr paul 1
News US clears Johnson & Johnson hepatitis C drug (Nov '13) Nov '13 WARNING FDA APPROVED 1
News DePuy ASR Hip Recall: Status Conference Held in... (Jan '13) Jul '13 Steve Austin 4
News J&J to stop selling metal-on-metal hip replacem... (May '13) Jul '13 Susan 2
News New Market Report: DePuy Medical Device Company... (Jun '12) Jul '13 Ray Lin 6
News Lawsuits filed over recalled hip joints (Jul '11) Jul '13 Bryan 10
More from around the web